Viewing StudyNCT00471081



Ignite Creation Date: 2024-05-05 @ 5:31 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00471081
Status: COMPLETED
Last Update Posted: 2019-06-25
First Post: 2007-05-08

Brief Title: Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Infections Meningococcal
Keywords:
Name View
Immunogenicity View
Neisseria meningitidis View
Humans View
Meningococcal vaccines View
Safety View
Vaccines conjugate View
Toddlers View